Replies to post #151756 on Bioelectronics Corp (BIEL)

[Simpsonly]

Thanks MJ....like how you think
Protex was clearly a wound/surgical dressing expert and since their re-boot has become strong in the difficult, nasty wound/sore space too.

I recall years ago BIEL talking up bed sores, butt and heel, and accelerated circulation at the site of long-term issues. Maybe Protex simply went to the CVS wound care/dressing buyer and said, "let's make a deal!"

Is this not great for BIEL and CVS and Protex, but mostly for perhaps 100's of thousands of people with slow-healing sore and circulation issues? BIEL said years ago wound healing was part of its space, it may be a soft launch because the wound-care buyer has zero advert and promo dollars compared to the pain buyer, look and compare the shelf space and SKU's ...maybe 10 to 1? 20 to 1?

As long as the CVS buyer points the story to the foot and knee, I say he/she, Protex and BIEL nailed it with innovative thinking! FDA would have to be happy too, no? I say hats off, once again to Andy Whelan and Keith Nalepka ..... brilliant, I would never have thought of that route onto U.S. pharma retail shelves.....wound-care pain of the foot and knee....absolutely brilliant market entry!

ActiPatch ...foot (persistent, nasty heel sores....bed sores) and knee wound-care pain at CVS...now! So brilliant, someone with a long-term bed heel sore is gonna get healed and ask, "I wonder if this ActiPatch gizmo will also work on the bedsores on my butt? Let's give it a try! Nurse, would you please slap another ActiPatch on my a$$ for me?" Andy Whelan knows all dem bones is connected to all dem bones. I'm smiling and sleepin like a baby....ha! Brilliant little engine that could...nothing stops a Whelan.....